熱門資訊> 正文
ClearBridge小盘股增长策略增加新头寸,退出其他头寸
2026-07-20 22:08
- ClearBridge Small-Cap Growth Strategy returned 21% in Q2 2026, underperforming the Russell 2000 Growth Index, which gained 26% during the same period.
- During Q2 2026, the strategy initiated 13 new positions: Argan (NYSE: AGX), Axsome Therapeutics (NASDAQ: AXSM), Cipher Digital (NASDAQ: CIFR), D-Wave Quantum (NYSE: QBTS), DigitalOcean Holdings (NYSE: DOCN), Hut 8 (NASDAQ: HUT), Kymera Therapeutics (NASDAQ: KYMR), Legence (NASDAQ: LGN), Liftoff Mobile (NASDAQ: LFTO), MaxLinear (NASDAQ: MXL), MYR Group (NASDAQ: MYRG), Praxis Precision Medicines (NASDAQ: PRAX), and Solaris Energy Infrastructure (NYSE: SEI).
- The strategy fully exited positions in e.l.f. Beauty (NYSE: ELF), Ensign Group (NASDAQ: ENSG), IonQ (NYSE: IONQ), Limbach Holdings (NASDAQ: LMB), and Penumbra (NYSE: PEN).
- Source.
More on Argan, Axsome Therapeutics, etc.
- D-Wave Quantum Says 2 Protocols Are Better Than One, And I Agree: Strong Buy
- SEI: Buy Before The S&P 600 Flows Arrive
- Argan: Solid Visibility And Disciplined Execution Still Justifies A Buy
- Hut 8 stock rises after tenant doubles footprint at Beacon Point data center site in Texas
- Quant snapshot: MXL, INTC lead top-rated names as AMAL and FRME lag
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。